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DNA replication is an important event for all living organ-
isms and the mechanism is essentially conserved from ar-
chaea, bacteria to eukaryotes. Proliferating cell nuclear an-
tigen (PCNA) acts as the universal platform for many DNA 
transacting proteins. Flap endonuclease 1 (FEN1) is one 
such enzyme whose activity is largely affected by the in-
teraction with PCNA. To elucidate the key interactions be-
tween plant PCNA and FEN1 and possible structural change 
of PCNA caused by binding of FEN1 at the atomic level, 
crystallization and preliminary studies of X-ray diffraction of 
crystals of Arabidopsis thaliana PCNA2 (AtPCNA2) alone and 
in a complex with a peptide derived from AtFEN1, which 
contains a typical PCNA-interacting protein (PIP)-box mo-
tif, were performed. Both peptide-free and peptide-bound 
AtPCNA2s were crystallized using the same reservoir so-
lution but in different crystal systems, indicating that the 
peptide affected the intermolecular interactions in the crys-
tals. Crystals of AtPCNA2 belonged to the hexagonal space 
group P63, while those of the peptide-bound AtPCNA2 
belonged to the rhombohedral space group H3, both of 
which could contain the functional homo-trimers.
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INTRODUCTION
Genomic DNA replication requires over 50 kinds of pro-
tein which work in a highly coordinated manner by form-
ing a large assembly called a replisome (Masai et al., 2010). 
The mechanism of DNA replication is conserved from ar-
chaea, bacteria to eukaryotes. PCNA is one of the most es-
sential proteins involved in DNA metabolic processes such 
as replication, repair and recombination. PCNA recruits and 
regulates the DNA metabolizing proteins by tethering them 
onto DNA (Moldovan et al., 2007). PCNA possesses a ring 
structure formed by the three identical subunits suitable for 
encircling DNA. PCNA is topologically linked to DNA by 
the ATP-dependent action of clamp-loader called RFC (rep-
lication factor C) (Yao & O’Donnell, 2012). PCNA binds 
different proteins involved in DNA metabolism by recog-
nizing the canonical motif called the PCNA-interacting pro-
tein (PIP)-box, which is usually located at the C-terminus 
of the partner protein (Warbrick, 1998). Although the con-
servation of the PIP-box motif sequence is moderate, the 
binding mode of PIP-box peptides to PCNA is similar, as 
shown by many crystallographic studies (Gulbis et al., 1996; 
Matsumiya et al., 2002; Bubeck et al., 2011). Recently, other 
PCNA-binding motifs have been identified and character-
ized by structural biology, which showed the unique bind-
ing mode of these non-canonical motifs to PCNAs (Hishiki 
et al., 2009; Sebesta et al., 2017).
Previously, we studied the functional and structural as-
pects of Arabidopsis thaliana PCNA proteins. They are des-
ignated as AtPCNA1 (molecular mass Mr: 30 508 Da) and 
AtPCNA2 (Mr: 30 335 Da), which are in 96% identical to 
each other, and show significant homology to human and 
archaeal PCNAs (Strzalka et al., 2009). We determined the 
atomic structure of the two Arabidopsis PCNAs complexed 
with the canonical PIP-box peptide derived from human 
cyclin-dependent kinase inhibitor, p21/WAF-1, using X-ray 
crystallography. The structure of the plant PCNAs showed 
the basic conservation in comparison to human and archae-
al PCNA, and a possible functional binding mode of the 
PIP-box. Flap endonuclease 1 (FEN1) is a structure-specific 
nuclease which removes the 5’ protruded flap nucleotide 
generated during DNA replication and repair. In particular, 
the removal of RNA primers from the nascent strands in 
DNA replication by the action of FEN1 is essential for the 
maturation of Okazaki fragments. Human FEN1 activity is 
stimulated by the interaction with PCNA via the PIP-box 
peptide (Chapados et al., 2004; Bruning & Shamoo, 2004). 
The crystal structures of human and archaeal FEN1s in 
various states such as FEN1 alone (Hwang et al., 1998; 
Hosfield et al., 1998), in complexes with DNA (Chapados 
et al., 2004; Tsutakawa et al., 2011) or with PCNA (Sakurai 
et al., 2005; Doré et al., 2006) were investigated. However, 
corresponding studies related to the plant FEN1 were not 
reported yet.
To explore the structural aspects of plant PCNA and 
FEN1 interactions, including possible structural change of 
PCNA associated with binding of FEN1, crystallographic 
studies of the Arabidopsis PCNA2-FEN1 PIP-box peptide 
complex as well as the isolated form of AtPCNA2 were 
performed. Here, we describe the purification, crystallization 
and study of the preliminary X-ray diffraction of AtPCNA2 
alone and its complex with a PIP-box peptide derived from 
the Arabidopsis FEN1. In particular, we for the first time 
succeeded in the crystallization of the peptide-free AtPC-
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NA2, which allows revealing the possible structural change 
of AtPCNA2 caused by the binding of DNA metabolizing 
proteins such as AtFEN1.
MATERIALS AND METHODS
Overexpression and Purification. The Escherichia coli 
BL21 (DE3) Rosetta strain (Novagen) was used for AtPC-
NA2 protein production. Cells transformed with pET15b 
vector coding for AtPCNA2 (Strzalka et al., 2009) fused 
with histidine tag were grown at 310 K using LB medium 
supplemented with 30 mg l–1 chloramphenicol and 100 mg 
l–1 ampicillin. Protein overexpression was induced using 1 
mM isopropyl β-d-1-thiogalactopyranoside (IPTG) when 
OD600 of the culture reached ~ 0.5. Bacteria were cultured 
by shaking vigorously at 310 K for 4 h then followed by 
centrifugation (10 min, 12 000 × g, 277 K). The pellet from 
1 l of culture was resuspended in 40 ml of binding buffer 
A (50 mM sodium phosphate, 300 mM NaCl, 20 mM imi-
dazole, pH 7.5) which contained an EDTA-free protease 
inhibitor cocktail (Roche). Bacteria were sonicated for 15 
min (5 s pulse followed by a 15 s pause, QSonica Q700 
sonicator, USA). The cell lysate containing the AtPCNA2 
protein was supplemented with 200 units of DNase I (Ta-
kara Bio, Japan) and incubated for 20 min on ice. Then, 
the lysate was centrifuged (20 min, 21 000 × g, 277 K) and 
the supernatant was loaded onto HisTrap FF Ni Sepharose 
(5 ml, GE Healthcare, Sweden). The protein was purified 
according to the protocols supplied by the manufacturers. 
After being eluted from the nickel resin, the AtPCNA2 was 
dialyzed into buffer B (50 mM Tris–HCl pH 7.6) and load-
ed onto the anion exchange HiTrap Q column (5 ml, GE 
Healthcare, Sweden). The protein elution was performed 
using a linear NaCl gradient from 0 to 1 M (10 volumes of 
the column). The protein was eluted when NaCl concentra-
tion was around 0.5 M NaCl. The purified AtPCNA2 was 
dialyzed against buffer C (50 mM Tris–HCl, 200 mM NaCl, 
0.2 mM EDTA, pH 8.0), supplemented with glycerol (final 
Table 1. Data collection and processing
Protein complex AtPCNA2 AtPCNA2-Fen1 PIP complex
Diffraction source Rigaku MicroMax-007 HF Rigaku FR-E
Wavelength (Å) 1.5418 1.5418 
Temperature (K) 100 100
Detector R-AXIS VII R-AXIS VII
Crystal-to-detector distance (mm) 200 175
Rotation range per image (°) 0.5 0.5
Exposure time per image (s) 300 270
Space group P63 H3
Unit cell constants
a, b, c (Å) 93.95, 93.95, 63.54 224.17, 224.17, 199.73
α, β, γ (°) 90, 90, 120 90, 90, 120
Mosaicity (°) 0.30 0.10 
Resolution range (Å) 50.0-2.65 (2.78-2.65) 50.0-2.85 (2.90-2.85)
Total No. of observed reflections 63 486 (8383) 366 082 (18 559)
No. of unique reflections 9385 (1228) 87 329 (4497)
Completeness (%) 99.8 (99.5) 99.9 (100.0)
Multiplicity 6.8 (6.8) 4.2 (4.1)
I/σ(I) 22.2 (3.1) 9.5 (2.2)
Rmeas 0.068 (0.735) 0.185 (0.863)
Rmerge 0.057 (0.623) 0.142 (0.658)
Half-set correlation CC1/2 0.999 (0.791) 0.990 (0.654)
Overall B factor from Wilson plot (Å2) 57.6 31.9
Values for the outer shell are given in parentheses.
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concentration 15% (v/v)) and stored at 193 K for further 
experiments.
The 22-amino acid long peptide containing the PCNA 
interacting protein (PIP)-box from A. thaliana endonucle-
ase FEN1 (334-KNKSSQGRLESFFKPVANSSVP-355) 
was commercially synthesized (LifeTein LLC, New Jersey, 
USA).
Crystallization. The protein was crystallized using the 
hanging-drop vapour diffusion method at 293 K. Ac-
cording to the previous crystallization experiment of At-
PCNAs complexed with human p21 peptide (Strzalka et 
al., 2009), a reservoir containing 100 mM citric acid pH 
4.5 and 1.2 to 1.8 M ammonium sulfate was used for 
both AtPCNA2 alone and the complex with the peptide. 
AtPCNA2 used for crystallization was concentrated to 
20 mg ml-1 in buffer C deprived of glycerol. In the case 
of the complex crystallization, the peptide was added to 
the protein at a 1.5 molar ratio (assuming AtPCNA2 as 
a monomer) and incubated at 289 K for 30 min. Crystal-
lization drops were produced by mixing equal volumes 
(1 µl) of the protein and reservoir solutions and then 
placed against the reservoir solution (500 µl). Crystals of 
the peptide-free and peptide-bound AtPCNA2s grew to 
a maximum dimension of approximately 200 µm within 
a week.
X-ray diffraction data collection. X-ray diffrac-
tion data were collected using an in-house imaging plate 
detector R-AXIS VII (Rigaku) equipped with an X-ray 
generator either MicroMax-007 HF or FR-E (Rigaku). 
Crystals were cryo-harvested by soaking them into the 
mother liquor supplemented with either 30% (v/v) eth-
ylene glycol for AtPCNA2 crystals or 20% (v/v) glycerol 
for the AtPCNA2-AtFEN1 PIP-box peptide complex 
for several seconds, and then flash-cooled in liquid ni-
trogen. The detailed X-ray diffraction experiment condi-
tions and the data statistics are listed in Table 1. The 
data were processed by the XDS (Kabsch, 2010), Point-
less (Evans, 2006), and Aimless (Evans & Murshudov, 
2013) programs. The number of molecules in the asym-




We previously succeeded in crystallizing the human 
p21-derived peptide-bound plant PCNAs which were 
purified using HisTrap as the only column chromatog-
raphy method  (Strzalka et al., 2009). In this study, us-
ing two-step column chromatography we purified AtPC-
NA2 (Fig. 1). The genomic DNA from the E. coli cells 
was degraded into small fragments during sonication 
and DNase I treatment. Next, most of these fragments 
were removed at the first stage of the protein purifica-
tion when the HisTrap column was used. The DNA re-
maining in the protein sample eluted from the HisTrap 
column was separated from AtPCNA2 using the HiTrap 
Q column (data not shown). Using a protein sample of 
higher purity than previously (Strzalka et al., 2009) we 
were able to crystallize AtPCNA2 free of the ligand as 
well as complexed with the PIP-box peptide derived 
from the AtFEN1. Interestingly, both the peptide-free 
and peptide-bound AtPCNA2 crystallized under the 
same reservoir conditions but in different crystal forms 
(Fig. 2), as revealed by the following crystallographic 
analysis. The peptide used for the present study affected 
the packing interactions of AtPCNA2 in the crystals.
X-ray crystallographic study
The AtPCNA2 crystals diffracted the X-rays from an
in-house generator to a resolution of 2.65 Å, and the 
AtPCNA2-AtFEN1 PIP-box peptide complex to 2.85 
Å (Fig. 3 and Table 1). The AtPCNA2 crystals alone 
belong to the hexagonal space group P63, with unit cell 
constants of a=b=93.95 Å, c=63.54 Å, and probably 
contain the one subunit in the asymmetric unit with a 
Matthews coefficient (VM) of 2.68 Å3 Da-1 and a solvent 
content of 54%. These crystallographic parameters are 
similar to those for homologous PCNAs (Matsumiya 
et al., 2001; Ladner et al., 2011) which suggests that in 
the AtPCNA2 crystals monomers form homotrimers 
with crystallographic symmetry-related molecules. On 
the other hand, the AtPCNA2-AtFEN1 PIP-box pep-
tide complex crystals belong to the space group H3 with 
unit cell constants of a=b=224.17 Å, c=199.73 Å. The 
space group and unit cell constants of the crystal of this 
complex are similar to those of the previous AtPCNA2-
human p21 peptide complex crystal which contains eight 
complex molecules in the asymmetric unit with two 
monomers that form the symmetry-related homotrimers 
and the two independent homotrimers. If the crystal of 
the AtPCNA2/AtFEN1 PIP-box peptide complex has a 
molecular arrangement in the crystal very similar to that 
Figure 1. Purification of AtPCNA2. (a) SDS-PAGE analysis (12%) 
of AtPCNA2 after each purification step. The proteins were 
stained using Coomassie Brilliant Blue. 
Lanes: M, molecular mass standards with sizes indicated on the 
left; 1, E. coli supernatant after sonication containing AtPCNA2; 
2, AtPCNA2 after purification using HisTrap Ni-chelating affinity 
chromatography; 3,  AtPCNA2 purified using  HisTrap Ni-chelating 
affinity chromatography followed by  HiTrap Q anion-exchange 
chromatography.
Figure 2. Crystals of (a) ligand-free AtPCNA2 and (b) AtPCNA2-
FEN1 PIP-box peptide complex. 
The scale bar is 100 µm.
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of the AtPCNA2-human p21 peptide complex, it leads 
to a VM of 3.66 Å3Da–1 and a solvent content of 66%. 
Despite the fact that both the peptide-free and peptide-
bound AtPCNA2 proteins were crystallized using the 
same reservoir solution, two different forms of crystals 
were obtained, one type for AtPCNA2 and the other for 
peptide-bound AtPCNA2. Determining the structure of 
these complexes at the atomic level would give us an an-
swer whether the peptide-bound AtPCNA2 complex dis-
plays unique and different inter-homotrimer interactions 
in the crystal, as compared to those in the ligand-free 
AtPCNA2 crystal. This information would be significant 
in the context of a detailed understanding of the role of 
PCNA in FEN1-dependent DNA replication in plants. 
Although we solved both crystal structures by the mo-
lecular replacement method, the quality of the electron 
density maps was too poor to build accurate atomic 
models. Therefore, the preparation of the better quality 
crystals is in progress to obtain high-quality X-ray dif-
fraction data at synchrotron radiation facility beamlines.
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